AS Latvijas Juras medicinas centrs

RISE:LJM1R Stock Report

Market Cap: €5.3m

AS Latvijas Juras medicinas centrs Management

Management criteria checks 2/4

AS Latvijas Juras medicinas centrs' CEO is Janis Birks, appointed in Aug 2009, has a tenure of 15.33 years. directly owns 12.8% of the company’s shares, worth €675.84K. The average tenure of the management team and the board of directors is 10.9 years and 14.7 years respectively.

Key information

Janis Birks

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure15.3yrs
CEO ownership12.8%
Management average tenure10.9yrs
Board average tenure14.7yrs

Recent management updates

Recent updates

CEO

Janis Birks (68 yo)

15.3yrs

Tenure

€90,547

Compensation

Janis Birks has been the Chairman of the Management Board at AS Latvijas Juras medicinas centrs since August 2009.

Leadership Team

NamePositionTenureCompensationOwnership
Janis Birks
Chairman of the Management Board15.3yrs€90.55k12.8%
€ 675.8k
Juris Imaks
Member of Management Board10.9yrs€69.22kno data
S. Zadoroznijs
Member of the Boardless than a yearno datano data
Gunta Kaufmane
Chief Accountantno datano datano data

10.9yrs

Average Tenure

Experienced Management: LJM1R's management team is seasoned and experienced (10.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Uldis Osis
Member of the Council14.7yrs€4.78kno data
Martins Birks
Chairman of the Council18.1yrs€8.20k17.5%
€ 924.0k
Ineta Gadzjus
Member of the Council14.7yrs€5.63kno data
Jevgenijs Kalejs
Member of the Council14.7yrs€4.78kno data
Viesturs Silins
Deputy Chairman of the Councilno data€5.63kno data

14.7yrs

Average Tenure

Experienced Board: LJM1R's board of directors are seasoned and experienced ( 14.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 15:10
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AS Latvijas Juras medicinas centrs is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution